The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Approved COVID-19 Vaccines Market Research Report 2025
Synopsis
The global Approved COVID-19 Vaccines market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Approved COVID-19 Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Approved COVID-19 Vaccines.
Report Scope
The Approved COVID-19 Vaccines market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Approved COVID-19 Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Approved COVID-19 Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Moderna
CanSino Biologicals
Inovio Pharmaceuticals
Shenzhen Geno-Immune Medical Institute
GlaxoSmithKine
Pfizer
Johnson＆Johnson
Heat Biologics
Sanofi
Segment by Type
Component Viral Vaccines
Whole Virus Vaccines
Segment by Application
Adults
Children
Elderly
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Approved COVID-19 Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Approved COVID-19 Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Approved COVID-19 Vaccines market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Approved COVID-19 Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Approved COVID-19 Vaccines.
Report Scope
The Approved COVID-19 Vaccines market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Approved COVID-19 Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Approved COVID-19 Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Moderna
CanSino Biologicals
Inovio Pharmaceuticals
Shenzhen Geno-Immune Medical Institute
GlaxoSmithKine
Pfizer
Johnson＆Johnson
Heat Biologics
Sanofi
Segment by Type
Component Viral Vaccines
Whole Virus Vaccines
Segment by Application
Adults
Children
Elderly
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Approved COVID-19 Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Approved COVID-19 Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Approved COVID-19 Vaccines Market Overview
1.1 Product Overview and Scope of Approved COVID-19 Vaccines
1.2 Approved COVID-19 Vaccines Segment by Type
1.2.1 Global Approved COVID-19 Vaccines Market Value Comparison by Type (2024-2030)
1.2.2 Component Viral Vaccines
1.2.3 Whole Virus Vaccines
1.3 Approved COVID-19 Vaccines Segment by Application
1.3.1 Global Approved COVID-19 Vaccines Market Value by Application: (2024-2030)
1.3.2 Adults
1.3.3 Children
1.3.4 Elderly
1.4 Global Approved COVID-19 Vaccines Market Size Estimates and Forecasts
1.4.1 Global Approved COVID-19 Vaccines Revenue 2019-2030
1.4.2 Global Approved COVID-19 Vaccines Sales 2019-2030
1.4.3 Global Approved COVID-19 Vaccines Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Approved COVID-19 Vaccines Market Competition by Manufacturers
2.1 Global Approved COVID-19 Vaccines Sales Market Share by Manufacturers (2019-2024)
2.2 Global Approved COVID-19 Vaccines Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Approved COVID-19 Vaccines Average Price by Manufacturers (2019-2024)
2.4 Global Approved COVID-19 Vaccines Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Approved COVID-19 Vaccines, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Approved COVID-19 Vaccines, Product Type & Application
2.7 Approved COVID-19 Vaccines Market Competitive Situation and Trends
2.7.1 Approved COVID-19 Vaccines Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Approved COVID-19 Vaccines Players Market Share by Revenue
2.7.3 Global Approved COVID-19 Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Approved COVID-19 Vaccines Retrospective Market Scenario by Region
3.1 Global Approved COVID-19 Vaccines Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Approved COVID-19 Vaccines Global Approved COVID-19 Vaccines Sales by Region: 2019-2030
3.2.1 Global Approved COVID-19 Vaccines Sales by Region: 2019-2024
3.2.2 Global Approved COVID-19 Vaccines Sales by Region: 2025-2030
3.3 Global Approved COVID-19 Vaccines Global Approved COVID-19 Vaccines Revenue by Region: 2019-2030
3.3.1 Global Approved COVID-19 Vaccines Revenue by Region: 2019-2024
3.3.2 Global Approved COVID-19 Vaccines Revenue by Region: 2025-2030
3.4 North America Approved COVID-19 Vaccines Market Facts & Figures by Country
3.4.1 North America Approved COVID-19 Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Approved COVID-19 Vaccines Sales by Country (2019-2030)
3.4.3 North America Approved COVID-19 Vaccines Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Approved COVID-19 Vaccines Market Facts & Figures by Country
3.5.1 Europe Approved COVID-19 Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Approved COVID-19 Vaccines Sales by Country (2019-2030)
3.5.3 Europe Approved COVID-19 Vaccines Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Approved COVID-19 Vaccines Market Facts & Figures by Country
3.6.1 Asia Pacific Approved COVID-19 Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Approved COVID-19 Vaccines Sales by Country (2019-2030)
3.6.3 Asia Pacific Approved COVID-19 Vaccines Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Approved COVID-19 Vaccines Market Facts & Figures by Country
3.7.1 Latin America Approved COVID-19 Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Approved COVID-19 Vaccines Sales by Country (2019-2030)
3.7.3 Latin America Approved COVID-19 Vaccines Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Approved COVID-19 Vaccines Market Facts & Figures by Country
3.8.1 Middle East and Africa Approved COVID-19 Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Approved COVID-19 Vaccines Sales by Country (2019-2030)
3.8.3 Middle East and Africa Approved COVID-19 Vaccines Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Approved COVID-19 Vaccines Sales by Type (2019-2030)
4.1.1 Global Approved COVID-19 Vaccines Sales by Type (2019-2024)
4.1.2 Global Approved COVID-19 Vaccines Sales by Type (2025-2030)
4.1.3 Global Approved COVID-19 Vaccines Sales Market Share by Type (2019-2030)
4.2 Global Approved COVID-19 Vaccines Revenue by Type (2019-2030)
4.2.1 Global Approved COVID-19 Vaccines Revenue by Type (2019-2024)
4.2.2 Global Approved COVID-19 Vaccines Revenue by Type (2025-2030)
4.2.3 Global Approved COVID-19 Vaccines Revenue Market Share by Type (2019-2030)
4.3 Global Approved COVID-19 Vaccines Price by Type (2019-2030)
5 Segment by Application
5.1 Global Approved COVID-19 Vaccines Sales by Application (2019-2030)
5.1.1 Global Approved COVID-19 Vaccines Sales by Application (2019-2024)
5.1.2 Global Approved COVID-19 Vaccines Sales by Application (2025-2030)
5.1.3 Global Approved COVID-19 Vaccines Sales Market Share by Application (2019-2030)
5.2 Global Approved COVID-19 Vaccines Revenue by Application (2019-2030)
5.2.1 Global Approved COVID-19 Vaccines Revenue by Application (2019-2024)
5.2.2 Global Approved COVID-19 Vaccines Revenue by Application (2025-2030)
5.2.3 Global Approved COVID-19 Vaccines Revenue Market Share by Application (2019-2030)
5.3 Global Approved COVID-19 Vaccines Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Moderna
6.1.1 Moderna Corporation Information
6.1.2 Moderna Description and Business Overview
6.1.3 Moderna Approved COVID-19 Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Moderna Approved COVID-19 Vaccines Product Portfolio
6.1.5 Moderna Recent Developments/Updates
6.2 CanSino Biologicals
6.2.1 CanSino Biologicals Corporation Information
6.2.2 CanSino Biologicals Description and Business Overview
6.2.3 CanSino Biologicals Approved COVID-19 Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.2.4 CanSino Biologicals Approved COVID-19 Vaccines Product Portfolio
6.2.5 CanSino Biologicals Recent Developments/Updates
6.3 Inovio Pharmaceuticals
6.3.1 Inovio Pharmaceuticals Corporation Information
6.3.2 Inovio Pharmaceuticals Description and Business Overview
6.3.3 Inovio Pharmaceuticals Approved COVID-19 Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Inovio Pharmaceuticals Approved COVID-19 Vaccines Product Portfolio
6.3.5 Inovio Pharmaceuticals Recent Developments/Updates
6.4 Shenzhen Geno-Immune Medical Institute
6.4.1 Shenzhen Geno-Immune Medical Institute Corporation Information
6.4.2 Shenzhen Geno-Immune Medical Institute Description and Business Overview
6.4.3 Shenzhen Geno-Immune Medical Institute Approved COVID-19 Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Shenzhen Geno-Immune Medical Institute Approved COVID-19 Vaccines Product Portfolio
6.4.5 Shenzhen Geno-Immune Medical Institute Recent Developments/Updates
6.5 GlaxoSmithKine
6.5.1 GlaxoSmithKine Corporation Information
6.5.2 GlaxoSmithKine Description and Business Overview
6.5.3 GlaxoSmithKine Approved COVID-19 Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.5.4 GlaxoSmithKine Approved COVID-19 Vaccines Product Portfolio
6.5.5 GlaxoSmithKine Recent Developments/Updates
6.6 Pfizer
6.6.1 Pfizer Corporation Information
6.6.2 Pfizer Description and Business Overview
6.6.3 Pfizer Approved COVID-19 Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Pfizer Approved COVID-19 Vaccines Product Portfolio
6.6.5 Pfizer Recent Developments/Updates
6.7 Johnson＆Johnson
6.6.1 Johnson＆Johnson Corporation Information
6.6.2 Johnson＆Johnson Description and Business Overview
6.6.3 Johnson＆Johnson Approved COVID-19 Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Johnson＆Johnson Approved COVID-19 Vaccines Product Portfolio
6.7.5 Johnson＆Johnson Recent Developments/Updates
6.8 Heat Biologics
6.8.1 Heat Biologics Corporation Information
6.8.2 Heat Biologics Description and Business Overview
6.8.3 Heat Biologics Approved COVID-19 Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Heat Biologics Approved COVID-19 Vaccines Product Portfolio
6.8.5 Heat Biologics Recent Developments/Updates
6.9 Sanofi
6.9.1 Sanofi Corporation Information
6.9.2 Sanofi Description and Business Overview
6.9.3 Sanofi Approved COVID-19 Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Sanofi Approved COVID-19 Vaccines Product Portfolio
6.9.5 Sanofi Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Approved COVID-19 Vaccines Industry Chain Analysis
7.2 Approved COVID-19 Vaccines Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Approved COVID-19 Vaccines Production Mode & Process
7.4 Approved COVID-19 Vaccines Sales and Marketing
7.4.1 Approved COVID-19 Vaccines Sales Channels
7.4.2 Approved COVID-19 Vaccines Distributors
7.5 Approved COVID-19 Vaccines Customers
8 Approved COVID-19 Vaccines Market Dynamics
8.1 Approved COVID-19 Vaccines Industry Trends
8.2 Approved COVID-19 Vaccines Market Drivers
8.3 Approved COVID-19 Vaccines Market Challenges
8.4 Approved COVID-19 Vaccines Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Approved COVID-19 Vaccines Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Approved COVID-19 Vaccines Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Approved COVID-19 Vaccines Market Competitive Situation by Manufacturers in 2023
Table 4. Global Approved COVID-19 Vaccines Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Approved COVID-19 Vaccines Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Approved COVID-19 Vaccines Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Approved COVID-19 Vaccines Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Approved COVID-19 Vaccines Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Approved COVID-19 Vaccines, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Approved COVID-19 Vaccines, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Approved COVID-19 Vaccines, Product Type & Application
Table 12. Global Key Manufacturers of Approved COVID-19 Vaccines, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Approved COVID-19 Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Approved COVID-19 Vaccines as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Approved COVID-19 Vaccines Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Approved COVID-19 Vaccines Sales by Region (2019-2024) & (K Units)
Table 18. Global Approved COVID-19 Vaccines Sales Market Share by Region (2019-2024)
Table 19. Global Approved COVID-19 Vaccines Sales by Region (2025-2030) & (K Units)
Table 20. Global Approved COVID-19 Vaccines Sales Market Share by Region (2025-2030)
Table 21. Global Approved COVID-19 Vaccines Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Approved COVID-19 Vaccines Revenue Market Share by Region (2019-2024)
Table 23. Global Approved COVID-19 Vaccines Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Approved COVID-19 Vaccines Revenue Market Share by Region (2025-2030)
Table 25. North America Approved COVID-19 Vaccines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Approved COVID-19 Vaccines Sales by Country (2019-2024) & (K Units)
Table 27. North America Approved COVID-19 Vaccines Sales by Country (2025-2030) & (K Units)
Table 28. North America Approved COVID-19 Vaccines Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Approved COVID-19 Vaccines Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Approved COVID-19 Vaccines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Approved COVID-19 Vaccines Sales by Country (2019-2024) & (K Units)
Table 32. Europe Approved COVID-19 Vaccines Sales by Country (2025-2030) & (K Units)
Table 33. Europe Approved COVID-19 Vaccines Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Approved COVID-19 Vaccines Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Approved COVID-19 Vaccines Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Approved COVID-19 Vaccines Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Approved COVID-19 Vaccines Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Approved COVID-19 Vaccines Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Approved COVID-19 Vaccines Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Approved COVID-19 Vaccines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Approved COVID-19 Vaccines Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Approved COVID-19 Vaccines Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Approved COVID-19 Vaccines Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Approved COVID-19 Vaccines Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Approved COVID-19 Vaccines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Approved COVID-19 Vaccines Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Approved COVID-19 Vaccines Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Approved COVID-19 Vaccines Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Approved COVID-19 Vaccines Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Approved COVID-19 Vaccines Sales (K Units) by Type (2019-2024)
Table 51. Global Approved COVID-19 Vaccines Sales (K Units) by Type (2025-2030)
Table 52. Global Approved COVID-19 Vaccines Sales Market Share by Type (2019-2024)
Table 53. Global Approved COVID-19 Vaccines Sales Market Share by Type (2025-2030)
Table 54. Global Approved COVID-19 Vaccines Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Approved COVID-19 Vaccines Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Approved COVID-19 Vaccines Revenue Market Share by Type (2019-2024)
Table 57. Global Approved COVID-19 Vaccines Revenue Market Share by Type (2025-2030)
Table 58. Global Approved COVID-19 Vaccines Price (US$/Unit) by Type (2019-2024)
Table 59. Global Approved COVID-19 Vaccines Price (US$/Unit) by Type (2025-2030)
Table 60. Global Approved COVID-19 Vaccines Sales (K Units) by Application (2019-2024)
Table 61. Global Approved COVID-19 Vaccines Sales (K Units) by Application (2025-2030)
Table 62. Global Approved COVID-19 Vaccines Sales Market Share by Application (2019-2024)
Table 63. Global Approved COVID-19 Vaccines Sales Market Share by Application (2025-2030)
Table 64. Global Approved COVID-19 Vaccines Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Approved COVID-19 Vaccines Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Approved COVID-19 Vaccines Revenue Market Share by Application (2019-2024)
Table 67. Global Approved COVID-19 Vaccines Revenue Market Share by Application (2025-2030)
Table 68. Global Approved COVID-19 Vaccines Price (US$/Unit) by Application (2019-2024)
Table 69. Global Approved COVID-19 Vaccines Price (US$/Unit) by Application (2025-2030)
Table 70. Moderna Corporation Information
Table 71. Moderna Description and Business Overview
Table 72. Moderna Approved COVID-19 Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Moderna Approved COVID-19 Vaccines Product
Table 74. Moderna Recent Developments/Updates
Table 75. CanSino Biologicals Corporation Information
Table 76. CanSino Biologicals Description and Business Overview
Table 77. CanSino Biologicals Approved COVID-19 Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. CanSino Biologicals Approved COVID-19 Vaccines Product
Table 79. CanSino Biologicals Recent Developments/Updates
Table 80. Inovio Pharmaceuticals Corporation Information
Table 81. Inovio Pharmaceuticals Description and Business Overview
Table 82. Inovio Pharmaceuticals Approved COVID-19 Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Inovio Pharmaceuticals Approved COVID-19 Vaccines Product
Table 84. Inovio Pharmaceuticals Recent Developments/Updates
Table 85. Shenzhen Geno-Immune Medical Institute Corporation Information
Table 86. Shenzhen Geno-Immune Medical Institute Description and Business Overview
Table 87. Shenzhen Geno-Immune Medical Institute Approved COVID-19 Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Shenzhen Geno-Immune Medical Institute Approved COVID-19 Vaccines Product
Table 89. Shenzhen Geno-Immune Medical Institute Recent Developments/Updates
Table 90. GlaxoSmithKine Corporation Information
Table 91. GlaxoSmithKine Description and Business Overview
Table 92. GlaxoSmithKine Approved COVID-19 Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. GlaxoSmithKine Approved COVID-19 Vaccines Product
Table 94. GlaxoSmithKine Recent Developments/Updates
Table 95. Pfizer Corporation Information
Table 96. Pfizer Description and Business Overview
Table 97. Pfizer Approved COVID-19 Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Pfizer Approved COVID-19 Vaccines Product
Table 99. Pfizer Recent Developments/Updates
Table 100. Johnson＆Johnson Corporation Information
Table 101. Johnson＆Johnson Description and Business Overview
Table 102. Johnson＆Johnson Approved COVID-19 Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Johnson＆Johnson Approved COVID-19 Vaccines Product
Table 104. Johnson＆Johnson Recent Developments/Updates
Table 105. Heat Biologics Corporation Information
Table 106. Heat Biologics Description and Business Overview
Table 107. Heat Biologics Approved COVID-19 Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Heat Biologics Approved COVID-19 Vaccines Product
Table 109. Heat Biologics Recent Developments/Updates
Table 110. Sanofi Corporation Information
Table 111. Sanofi Description and Business Overview
Table 112. Sanofi Approved COVID-19 Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Sanofi Approved COVID-19 Vaccines Product
Table 114. Sanofi Recent Developments/Updates
Table 115. Key Raw Materials Lists
Table 116. Raw Materials Key Suppliers Lists
Table 117. Approved COVID-19 Vaccines Distributors List
Table 118. Approved COVID-19 Vaccines Customers List
Table 119. Approved COVID-19 Vaccines Market Trends
Table 120. Approved COVID-19 Vaccines Market Drivers
Table 121. Approved COVID-19 Vaccines Market Challenges
Table 122. Approved COVID-19 Vaccines Market Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Approved COVID-19 Vaccines
Figure 2. Global Approved COVID-19 Vaccines Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Approved COVID-19 Vaccines Market Share by Type in 2023 & 2030
Figure 4. Component Viral Vaccines Product Picture
Figure 5. Whole Virus Vaccines Product Picture
Figure 6. Global Approved COVID-19 Vaccines Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Approved COVID-19 Vaccines Market Share by Application in 2023 & 2030
Figure 8. Adults
Figure 9. Children
Figure 10. Elderly
Figure 11. Global Approved COVID-19 Vaccines Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Approved COVID-19 Vaccines Market Size (2019-2030) & (US$ Million)
Figure 13. Global Approved COVID-19 Vaccines Sales (2019-2030) & (K Units)
Figure 14. Global Approved COVID-19 Vaccines Average Price (US$/Unit) & (2019-2030)
Figure 15. Approved COVID-19 Vaccines Report Years Considered
Figure 16. Approved COVID-19 Vaccines Sales Share by Manufacturers in 2023
Figure 17. Global Approved COVID-19 Vaccines Revenue Share by Manufacturers in 2023
Figure 18. The Global 5 and 10 Largest Approved COVID-19 Vaccines Players: Market Share by Revenue in 2023
Figure 19. Approved COVID-19 Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 20. Global Approved COVID-19 Vaccines Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 21. North America Approved COVID-19 Vaccines Sales Market Share by Country (2019-2030)
Figure 22. North America Approved COVID-19 Vaccines Revenue Market Share by Country (2019-2030)
Figure 23. United States Approved COVID-19 Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Canada Approved COVID-19 Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Europe Approved COVID-19 Vaccines Sales Market Share by Country (2019-2030)
Figure 26. Europe Approved COVID-19 Vaccines Revenue Market Share by Country (2019-2030)
Figure 27. Germany Approved COVID-19 Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. France Approved COVID-19 Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. U.K. Approved COVID-19 Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Italy Approved COVID-19 Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Russia Approved COVID-19 Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Approved COVID-19 Vaccines Sales Market Share by Region (2019-2030)
Figure 33. Asia Pacific Approved COVID-19 Vaccines Revenue Market Share by Region (2019-2030)
Figure 34. China Approved COVID-19 Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Japan Approved COVID-19 Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. South Korea Approved COVID-19 Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. India Approved COVID-19 Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Australia Approved COVID-19 Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. China Taiwan Approved COVID-19 Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Indonesia Approved COVID-19 Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Thailand Approved COVID-19 Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Malaysia Approved COVID-19 Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Latin America Approved COVID-19 Vaccines Sales Market Share by Country (2019-2030)
Figure 44. Latin America Approved COVID-19 Vaccines Revenue Market Share by Country (2019-2030)
Figure 45. Mexico Approved COVID-19 Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Brazil Approved COVID-19 Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Argentina Approved COVID-19 Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Colombia Approved COVID-19 Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Middle East & Africa Approved COVID-19 Vaccines Sales Market Share by Country (2019-2030)
Figure 50. Middle East & Africa Approved COVID-19 Vaccines Revenue Market Share by Country (2019-2030)
Figure 51. Turkey Approved COVID-19 Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Saudi Arabia Approved COVID-19 Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. UAE Approved COVID-19 Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Global Sales Market Share of Approved COVID-19 Vaccines by Type (2019-2030)
Figure 55. Global Revenue Market Share of Approved COVID-19 Vaccines by Type (2019-2030)
Figure 56. Global Approved COVID-19 Vaccines Price (US$/Unit) by Type (2019-2030)
Figure 57. Global Sales Market Share of Approved COVID-19 Vaccines by Application (2019-2030)
Figure 58. Global Revenue Market Share of Approved COVID-19 Vaccines by Application (2019-2030)
Figure 59. Global Approved COVID-19 Vaccines Price (US$/Unit) by Application (2019-2030)
Figure 60. Approved COVID-19 Vaccines Value Chain
Figure 61. Approved COVID-19 Vaccines Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
